契約製造企業がペプチド医薬品開発の将来をどのように形作っているのか ペプチド治療薬向け受託原薬（API）製造市場は、ペプチドベースの医薬品の開発および商業化を支援する第三者製造サービスに焦点を当てています。本市場分析では、2020年から2025年までの実績期間を検証するとともに、2025年から2030年までの見通し、および2035年までの長期予測を提供しています。市場動向は主要な世界各地域ごとに分 ...

Dublin, Jan. 08, 2025 (GLOBE NEWSWIRE) -- The "High Potency API Contract Manufacturing Market by Product, Synthesis, Application, Dosage Form, End User and Region" report has been added to ...

The global biotech API manufacturing services market, valued at US$ 38.9 Billion in 2022, is projected to grow at a CAGR of 7.1% from 2023 to 2031, surpassing US$ 73 Billion by 2031. biotech API ...

(MENAFN- IMARC Group) An API (Active Pharmaceutical Ingredient) is the biologically active component of a drug that produces the intended therapeutic effect. It is the essential substance in medicines ...

As supply chain vulnerabilities intensify and competition accelerates, the cost of this underutilization could risk India's competitive position.

Enveda has been using AI to power its drug discovery platform for several years. The company injected $230 million into funding the process through June 2024. Meanwhile, Phlow grew its analytical ...

Indian active pharmaceutical ingredient (API) companies should focus on efficient manufacturing practices and building partnerships with customers for a successful innings in the global arena, feel ...

Efficiency and adaptability are crucial in the ever-evolving manufacturing industry. As manufacturers adopt advanced technologies like IoT, AI, and cloud computing, the need for seamless integration ...